Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm AccuLift Laser Capture Microdissection System

Fluidigm has launched the AccuLift Laser Capture Microdissection System, which enables precise and efficient capture of individual cells or larger tissue regions from frozen and FFPE tissue sections for DNA, RNA, and protein biomarker analysis using sequencing, real-time PCR, or mass spectrometry. Fluidigm said that it collaborated with Lance Liotta, codirector of the Center for Applied Proteomics and Molecular Medicine at George Mason University, to develop the AccuLift product portfolio. The new system features a patent-pending design including a high-precision stage and uniquely aligned IR and UV lasers. It also features a new capture method developed in Liotta's laboratory that increases the efficiency of cellular capture and extraction.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.